RAG for Life Sciences: Provenance and Validation

Short answer: the retrieval problem in life sciences is not harder than elsewhere — the evidentiary requirements around it are. An answer that may inform a clinical decision or reach a regulatory submission needs per-claim provenance, a corpus version it can be reproduced against, and an evaluation set built by people who understand the domain. Generic RAG gives you none of those.

Most of what makes a life-sciences deployment different sits either side of retrieval rather than inside it.

Provenance is per claim, not per document

Consumer RAG cites a document. That is insufficient here.

If a generated summary states three facts drawn from two papers and an internal study report, each of those facts needs to resolve to a specific passage in a specific document — not a footnote pointing at a 300-page PDF. A reviewer must be able to check any individual claim in seconds, because they will, and because “it is in there somewhere” fails an audit.

Practically this means retaining passage-level identifiers through generation and attaching them per sentence or per claim, rather than appending a source list at the end. It constrains the generation step, and it is worth designing in from the start because retrofitting it means re-plumbing the whole pipeline.

Reproducibility of that kind has to be designed into ingestion, which is why it shapes the architecture from the first week of a regulated RAG build.

Answers must be reproducible against a corpus version

Corpora change. Protocols get amended, papers get retracted, labels get updated, internal reports get superseded.

An answer generated in March against the corpus as it stood in March cannot be reproduced in September if the index has silently moved on. For regulated work that reproducibility is often the requirement, not a nicety.

That means versioned ingestion: every document carries a version, the index records which versions it contains, and an answer records the corpus state it was generated against. It costs storage and adds ingestion complexity, and it is the difference between a system that survives an audit and one that cannot explain itself.

The related failure is staleness. An index a week behind will confidently cite a superseded protocol with no indication anything has changed. Freshness in this setting is a correctness property, not a performance one.

Compartmentalisation is the norm

Study data, trial results and commercially sensitive research are routinely restricted to specific teams, sites or roles. A single shared index that any authenticated user can query is a data-governance failure regardless of how good the retrieval is.

Permission-aware retrieval has to filter before the model sees passages, not after — filtering results post-generation means the model already read them. This constraint reaches back into ingestion and index design, which is why it is expensive to add late. The patterns are in enterprise RAG architecture.

The documents fight text extraction

Life-sciences corpora are unusually hostile to naive ingestion, and this is where most quality is lost before retrieval is even attempted.

Tables carry the results. Efficacy data, adverse event counts, dosing schedules. Flattened to a line of text, a table becomes numbers with no column meaning, and the model will confidently misattribute them. Never split rows; repeat headers into every chunk.

Figures carry findings. Dose-response curves, Kaplan-Meier plots, pathway diagrams. Text extraction returns a caption, if anything.

Structure is meaning. A protocol has numbered sections. A study report has a defined skeleton. Splitting on token counts destroys the hierarchy a reader relies on to interpret any individual passage.

Nomenclature is precise and ambiguous at once. Compound codes, gene symbols, brand versus generic names, abbreviations that differ by context. Pure vector search is unreliable on exact tokens — a query for a specific compound identifier needs lexical matching alongside semantic search, or it will return passages about similar-sounding compounds.

The fixes are structure-aware chunking, hybrid retrieval with BM25, and proper handling of tables and figures — see multimodal RAG.

The evaluation set needs domain experts

This is the part organisations under-resource, and it decides whether the system is trustworthy.

An evaluation set written by engineers tests whether the pipeline works. One written by scientists, regulatory staff or clinicians tests whether the answers are right in ways that matter — including the questions where the correct behaviour is to decline, or to surface a conflict between sources rather than picking one.

Include those negatives deliberately. A system that confidently answers a question the corpus cannot support is worse than one that says so, and you cannot measure that without cases where declining is the correct answer. The harness is described in RAG evaluation.

Where deployment constraints land

Much of this work cannot use hosted models, and the reasons are contractual as often as technical — data-sharing terms with partners, patient data under HIPAA or GDPR, or commercially sensitive pre-publication research.

The decision is usually not all-or-nothing. Self-hosted embeddings and a vector store you operate keep the corpus inside your boundary while still allowing a hosted model to generate over retrieved passages, if your agreements permit that. The three architectures and their real costs are laid out in on-premise RAG.

The takeaway

Design for provenance and reproducibility first — per-claim citations and versioned ingestion are extremely hard to retrofit and they are what the system will be judged on. Fix table and figure handling before tuning the model, since that is where most accuracy is lost. And build the evaluation set with domain experts, including the questions where the right answer is “the corpus does not support this”.

EpochC provides custom RAG development services for regulated corpora, plus healthcare AI built under HIPAA constraints. See the graph + vector retrieval case study — +40% query accuracy — or start a project.

RAG for life sciences: provenance, versioning and validated retrieval